Xenetic Biosciences, Inc. (XBIO)
4.20
-0.08
(-1.87%)
USD |
NASDAQ |
Sep 09, 15:01
Xenetic Biosciences 1 Year Total Returns (Daily) : 40.33% for Sept. 8, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 08, 2026 | 40.33% |
| September 04, 2026 | 51.84% |
| September 03, 2026 | 52.55% |
| September 02, 2026 | 39.88% |
| September 01, 2026 | 48.42% |
| August 31, 2026 | 47.02% |
| August 28, 2026 | 39.65% |
| August 27, 2026 | 39.79% |
| August 26, 2026 | 33.56% |
| August 25, 2026 | 33.57% |
| August 24, 2026 | 25.74% |
| August 21, 2026 | 27.31% |
| August 20, 2026 | 21.51% |
| August 19, 2026 | 19.23% |
| August 18, 2026 | 10.73% |
| August 17, 2026 | 13.99% |
| August 14, 2026 | 12.14% |
| August 13, 2026 | 10.03% |
| August 12, 2026 | 18.28% |
| August 11, 2026 | 16.67% |
| August 10, 2026 | 11.55% |
| August 07, 2026 | 6.73% |
| August 06, 2026 | -2.06% |
| August 05, 2026 | -6.48% |
| August 04, 2026 | -12.19% |
| Date | Value |
|---|---|
| August 03, 2026 | -17.26% |
| July 31, 2026 | -21.76% |
| July 30, 2026 | -22.02% |
| July 29, 2026 | -30.14% |
| July 28, 2026 | -31.35% |
| July 27, 2026 | -30.62% |
| July 24, 2026 | -27.47% |
| July 23, 2026 | -26.03% |
| July 22, 2026 | -25.21% |
| July 21, 2026 | -25.98% |
| July 20, 2026 | -23.22% |
| July 17, 2026 | -24.61% |
| July 16, 2026 | -22.59% |
| July 15, 2026 | -22.46% |
| July 14, 2026 | -18.03% |
| July 13, 2026 | -29.15% |
| July 10, 2026 | -28.62% |
| July 09, 2026 | -32.48% |
| July 08, 2026 | -31.04% |
| July 07, 2026 | -20.82% |
| July 06, 2026 | -22.97% |
| July 02, 2026 | -29.70% |
| July 01, 2026 | -21.60% |
| June 30, 2026 | -25.77% |
| June 29, 2026 | -19.26% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 213.2% |
| Oncolytics Biotech, Inc. | -37.11% |
| Sangamo Therapeutics, Inc. | -69.35% |
| Sarepta Therapeutics, Inc. | 18.98% |
| Anixa Biosciences, Inc. | -2.68% |